Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Loch

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 2, 2011
Discovery of bacterial NAD+-dependent DNA ligase inhibitors: optimization of antibacterial activitySuzanne S Stokes, Hoan Huynh, Madhusudhan Gowravaram, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2021
Positive allosteric modulators (PAMs) of the group II metabotropic glutamate receptors: Design, synthesis, and evaluation as ex-vivo tool compoundsYousuke Yamada, Kristen Gilliland, Zixiu Xiang, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2021
Discovery and optimization of a novel CNS penetrant series of mGlu<sub>4</sub> PAMs based on a 1,4-thiazepane core with in vivo efficacy in a preclinical Parkinsonian modelCaitlin N Kent, Mark G Fulton, Kaylee J Stillwell, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2016
Discovery and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu4)Rocco D Gogliotti, Anna L Blobaum, Ryan M Morrison, et al.
Journal of Medicinal Chemistry|May 16, 2014
Antibacterial inhibitors of Gram-positive thymidylate kinase: structure-activity relationships and chiral preference of a new hydrophobic binding regionSameer P Kawatkar, Thomas A Keating, Nelson B Olivier, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2011
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacyBrian A Sherer, Kenneth Hull, Oluyinka Green, et al.
ACS Chemical Neuroscience|July 22, 2016
Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 HeteromersColleen M Niswender, Carrie K Jones, Xin Lin, et al.
Journal of Medicinal Chemistry|September 25, 2018
Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1 H-Pyrazolo[4,3- b]pyridin-3-yl)amino)-benzo[ d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu<sub>4</sub>)Sean R Bollinger, Darren W Engers, Joseph D Panarese, et al.
Journal of Medicinal Chemistry|September 4, 2015
Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in RodentsJulie L Engers, Alice L Rodriguez, Leah C Konkol, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2015
Negishi cross-coupling enabled synthesis of novel NAD(+)-dependent DNA ligase inhibitors and SAR developmentKerry E Murphy-Benenato, Lakshmaiah Gingipalli, P Ann Boriack-Sjodin, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|July 2, 2011
Discovery of bacterial NAD+-dependent DNA ligase inhibitors: optimization of antibacterial activitySuzanne S Stokes, Hoan Huynh, Madhusudhan Gowravaram, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2021
Positive allosteric modulators (PAMs) of the group II metabotropic glutamate receptors: Design, synthesis, and evaluation as ex-vivo tool compoundsYousuke Yamada, Kristen Gilliland, Zixiu Xiang, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2021
Discovery and optimization of a novel CNS penetrant series of mGlu<sub>4</sub> PAMs based on a 1,4-thiazepane core with in vivo efficacy in a preclinical Parkinsonian modelCaitlin N Kent, Mark G Fulton, Kaylee J Stillwell, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2016
Discovery and characterization of a novel series of N-phenylsulfonyl-1H-pyrrole picolinamides as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu4)Rocco D Gogliotti, Anna L Blobaum, Ryan M Morrison, et al.
Journal of Medicinal Chemistry|May 16, 2014
Antibacterial inhibitors of Gram-positive thymidylate kinase: structure-activity relationships and chiral preference of a new hydrophobic binding regionSameer P Kawatkar, Thomas A Keating, Nelson B Olivier, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2011
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacyBrian A Sherer, Kenneth Hull, Oluyinka Green, et al.
ACS Chemical Neuroscience|July 22, 2016
Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 HeteromersColleen M Niswender, Carrie K Jones, Xin Lin, et al.
Journal of Medicinal Chemistry|September 25, 2018
Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1 H-Pyrazolo[4,3- b]pyridin-3-yl)amino)-benzo[ d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu<sub>4</sub>)Sean R Bollinger, Darren W Engers, Joseph D Panarese, et al.
Journal of Medicinal Chemistry|September 4, 2015
Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in RodentsJulie L Engers, Alice L Rodriguez, Leah C Konkol, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2015
Negishi cross-coupling enabled synthesis of novel NAD(+)-dependent DNA ligase inhibitors and SAR developmentKerry E Murphy-Benenato, Lakshmaiah Gingipalli, P Ann Boriack-Sjodin, et al.
Pageof 10